Search

Your search keyword '"Nößner E"' showing total 293 results

Search Constraints

Start Over You searched for: "Nößner E" Remove constraint "Nößner E"
293 results on '"Nößner E"'

Search Results

54. The EBNA-2 N-Terminal Transactivation Domain Folds into a Dimeric Structure Required for Target Gene Activation.

55. Application and new findings of scRNA-seq and ST-seq in prostate cancer.

56. Revolutionizing the treatment for nasopharyngeal cancer: the impact, challenges and strategies of stem cell and genetically engineered cell therapies.

57. Analysis of HLA-B35 variants andB35 haplotypes by isoelectric focusing and Southern blot analysis

58. Definition of HLA class I-associated DNA polymorphisms using anHLA-B locus-derived cDNA probe

59. Harnessing innate and adaptive immunity for adoptive cell therapy of renal cell carcinoma.

60. A polyvalent cellular vaccine induces T-cell responses against specific self-antigens overexpressed in chronic lymphocytic B-cell leukemia.

61. Antitumor effector functions of T cells are dependent on in vivo priming and restricted T-cell receptor expression.

62. Allorestricted T cells with specificity for the FMNL1-derived peptide PP2 have potent antitumor activity against hematologic and other malignancies.

63. Dendritic cell-based immunogens for B-cell chronic lymphocytic leukemia.

64. Immunological Tumor Microenvironment of Solitary Fibrous Tumors—Associating Immune Infiltrate with Variables of Prognostic Significance.

65. Identification of cancer stem cell-related genes through single cells and machine learning for predicting prostate cancer prognosis and immunotherapy.

66. The m6A regulators in prostate cancer: molecular basis and clinical perspective.

67. The role of ncRNAs and exosomes in the development and progression of endometrial cancer.

68. Prostate cancer stem cells and their targeted therapies.

69. Genome-Wide Identification and Interaction Analysis of Turbot Heat Shock Protein 40 and 70 Families Suggest the Mechanism of Chaperone Proteins Involved in Immune Response after Bacterial Infection.

70. Vaccination against B-cell chronic lymphocytic leukemia with trioma cells: preclinical evaluation.

71. The role of heat shock protein (hsp70) in dendritic cell maturation: hsp70 induces the maturation of immature dendritic cells but reduces DC differentiation from monocyte precursors.

72. Non-MHC-restricted CD4+ T lymphocytes are regulated by HLA-Cw7-mediated inhibition.

73. Cellular and molecular analyses of major histocompatibility complex (MHC) restricted and non-MHC-restricted effector cells recognizing renal cell carcinomas: problems and perspectives for immunotherapy.

75. Microheterogeneity in HLA-B35 alleles influences peptide-dependent allorecognition by cytotoxic T cells but not binding of a peptide-restricted monoclonal antibody.

76. Soluble T cell receptor-like properties of an HLA-B35-specific monoclonal antibody (TU165).

78. Genomic cloning and expression of HLA-B37 in the mouse mastocytoma cell line P815-HTR.

82. Autophagy-dependent regulation of MHC-I molecule presentation.

83. Virus-specific T-cells from third party or transplant donors for treatment of EBV lymphoproliferative diseases arising post hematopoietic cell or solid organ transplantation.

84. A Comprehensive Review of Immunotherapy Clinical Trials for Metastatic Urothelial Carcinoma: Immune Checkpoint Inhibitors Alone or in Combination, Novel Antibodies, Cellular Therapies, and Vaccines.

85. CD44v6, STn & O-GD2: promising tumor associated antigens paving the way for new targeted cancer therapies.

86. The dysfunction of CD8 + T cells triggered by endometriotic stromal cells promotes the immune survival of endometriosis.

88. CACYBP knockdown inhibits progression of prostate cancer via p53.

89. Cell Surface B2m-Free Human Leukocyte Antigen (HLA) Monomers and Dimers: Are They Neo-HLA Class and Proto-HLA?

92. Next Generation CD44v6-Specific CAR-NK Cells Effective against Triple Negative Breast Cancer.

93. Demethylating therapy increases cytotoxicity of CD44v6 CAR-T cells against acute myeloid leukemia.

94. Epigenetic modifications in esophageal cancer: An evolving biomarker.

95. Targeted Epigenetic Interventions in Cancer with an Emphasis on Pediatric Malignancies.

96. Role of Epitranscriptomic and Epigenetic Modifications during the Lytic and Latent Phases of Herpesvirus Infections.

97. CAR-T Cells in the Treatment of Urologic Neoplasms: Present and Future.

98. Reconstitution of EBV-directed T cell immunity by adoptive transfer of peptide-stimulated T cells in a patient after allogeneic stem cell transplantation for AITL.

99. Extracellular HSPs: The Potential Target for Human Disease Therapy.

100. Genome Assembly and Genome Annotation of Leishmania martiniquensis Isolated from a Leishmaniasis Patient in Thailand.

Catalog

Books, media, physical & digital resources